A Prospective, Multicenter Trial evaluating Efficacy, Safety and Quality of Life of Sacral Neuromodulation through 24 Months in Subjects with Symptoms of Overactive Bladder

Abstract Category

Neurourology

Links
	Abstract 708
	Electrostimulation Scientific Podium Poster Session 48
	Friday 24th October 2014
	12:05 - 12:10
	Room 1
	Clinical Trial Overactive Bladder Neuromodulation
	1. University of California, Irvine, 2. Stanford University, 3. Female Pelvic Medicine, 4. MetroHealth Medical Center, 5. Scott and White Healthcare, 6. University of Kansas, 7. Milford Regional Medical Center, 8. University of Oklahoma, 9. University of Washington, Seattle, 10. Medtronic, 11. Metro Urology
Presenter
K Karen Noblett
Abstract PDF Edit Abstract Abstract Centre